Back to VRTX

VERTEX PHARMACEUTICALS INC / MA Interest Expense 2008-2020 | VRTX

Beta

What is interest expense?

Interest expense represents the cost of borrowing money, including interest paid on bonds, loans, and other debt obligations.

What is VERTEX PHARMACEUTICALS INC / MA's current interest expense?

VERTEX PHARMACEUTICALS INC / MA (VRTX) annual interest expense for 2020 was $58.2M, a 0.60% decline from 2019. VERTEX PHARMACEUTICALS INC / MA interest expense for the quarter ending December 31, 2020 was $16.3M.

What was VERTEX PHARMACEUTICALS INC / MA's interest expense in 2019?

VERTEX PHARMACEUTICALS INC / MA annual interest expense for 2019 was $58.5M, a 19.28% decline from 2018.

What was VERTEX PHARMACEUTICALS INC / MA's interest expense in 2018?

VERTEX PHARMACEUTICALS INC / MA annual interest expense for 2018 was $72.5M, a 4.58% increase from 2017.

What is VERTEX PHARMACEUTICALS INC / MA's 3-year interest expense CAGR?

VERTEX PHARMACEUTICALS INC / MA interest expense grew at a compound annual growth rate (CAGR) of 5.68% from FY2017 to FY2020, going from $69.3M to $58.2M over 3 years.

Interest Expense History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+8.6%
FY2011
$38.5M
FY2020
$58.2M
080910111217181920
5 years selected
Interest Expense History
PeriodValueChangeSource
FY2020$58.2M-0.6%10-K
FY2019$58.5M-19.3%10-K
FY2018$72.5M+4.6%10-K
FY2017$69.3M+316.1%10-K
FY2012$16.7M-56.7%10-K
FY2011$38.5M+99.5%10-K
FY2010$19.3M+46.1%10-K
FY2009$13.2M-2.1%10-K
FY2008$13.5M-10-K
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →